KDR and type 2 diabetes mellitus: Ruszkowska-Ciastek et al. investigated the concentrations of VEGF-A and its receptors, VEGFR1 and VEGFR2, in patients with well-controlled type 2 diabetes mellitus (T2DM) who exhibited no vascular complications [56].